Cargando…
xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain
Cancers in the bone produce a number of severe symptoms including pain that compromises patient functional status, quality of life, and survival. The source of this pain is multifaceted and includes factors secreted from tumor cells. Malignant cells release the neurotransmitter and cell-signaling mo...
Autores principales: | Ungard, Robert G, Linher-Melville, Katja, Nashed, Mina G., Sharma, Manu, Wen, Jianping, Singh, Gurmit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329019/ https://www.ncbi.nlm.nih.gov/pubmed/30799686 http://dx.doi.org/10.1177/1744806918822185 |
Ejemplares similares
-
Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity
por: Linher-Melville, Katja, et al.
Publicado: (2016) -
Expression of xCT and activity of system x(c)(−) are regulated by NRF2 in human breast cancer cells in response to oxidative stress
por: Habib, Eric, et al.
Publicado: (2015) -
Inhibiting STAT3 in a murine model of human breast cancer-induced bone pain delays the onset of nociception
por: Linher-Melville, Katja, et al.
Publicado: (2019) -
STAT3 Inhibition in a Murine Model of Human Breast Cancer-Induced Bone Pain Delays Onset of Nociception
por: Sharma, Manu, et al.
Publicado: (2019) -
Functional effects of TrkA inhibition on system x(C)(−)-mediated glutamate release and cancer-induced bone pain
por: Miladinovic, Tanya, et al.
Publicado: (2018)